Silgan Holdings (SLGN)
(Real Time Quote from BATS)
$50.72 USD
-0.88 (-1.71%)
Updated Oct 3, 2024 03:54 PM ET
After-Market: $50.75 +0.03 (0.06%) 4:18 PM ET
3-Hold of 5 3
B Value B Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$50.72 USD
-0.88 (-1.71%)
Updated Oct 3, 2024 03:54 PM ET
After-Market: $50.75 +0.03 (0.06%) 4:18 PM ET
3-Hold of 5 3
B Value B Growth D Momentum B VGM
Zacks News
Is Silgan Holdings (SLGN) Stock Outpacing Its Industrial Products Peers This Year?
by Zacks Equity Research
Is (SLGN) Outperforming Other Industrial Products Stocks This Year?
Using ROE to Select Stocks
by Sejuti Banerjea
Clubbing ROE with the Zacks Rank, industry rank and other criteria is a neat way to select stocks.
Zacks.com featured highlights include: Westlake Chemical Partners, Silgan Holdings, Standard Motor, ePlus and AAR Corp
by Zacks Equity Research
Zacks.com featured highlights include: Westlake Chemical Partners, Silgan Holdings, Standard Motor, ePlus and AAR Corp
7 Stocks With Low Price-to-Sales That Are Worth Betting On
by Rajani Lohia
A stock's price-to-sales ratio reflects how much investors are paying for each dollar of revenues generated by a company.
Silgan (SLGN) Q3 Earnings Beat, Stock Down on Weak Q4 View
by Zacks Equity Research
Silgan (SLGN) delivers better-than-expected third-quarter results on solid demand for food, health and hygiene products amid the COVID-19 pandemic.
AptarGroup (ATR) Suffers From Weak End Markets Amid Pandemic
by Zacks Equity Research
AptarGroup's (ATR) third-quarter 2020 results are likely to reflect higher demand for pharmaceutical products amid the COVID-19 pandemic. However, weak beauty products sales will negate these gains.
Avery Dennison (AVY) Q3 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Avery Dennison (AVY) reports year-over-year improvement in third-quarter 2020 earnings despite decline in revenues, primarily driven by cost reduction initiatives.
Crown (CCK) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Crown (CCK) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Silgan Holdings (SLGN) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Silgan (SLGN) delivered earnings and revenue surprises of 9.47% and 2.34%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Pentair (PNR) Beats on Q3 Earnings & Sales, Ups '20 View
by Zacks Equity Research
Pentair (PNR) delivers better-than-expected third-quarter performance and projects adjusted earnings per share (EPS) between $2.35 and $2.40 for the current year.
Should You Buy Silgan (SLGN) Ahead of Earnings?
by Zacks Equity Research
Silgan (SLGN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
The Zacks Analyst Blog Highlights: Abbott Laboratories, NextEra Energy, Silgan Holdings, UniFirst Corp and Landstar System
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Abbott Laboratories, NextEra Energy, Silgan Holdings, UniFirst Corp and Landstar System
An Investment Strategy for Q3 Earnings in a Volatile Market
by Nalak Das
Investment in low-beats stocks with a favorable Zacks Rank and positive Earnings ESP will be a sound strategy to enhance one's portfolio.
Silgan Holdings (SLGN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Silgan (SLGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Silgan (SLGN) Hits 52-Week High: What's Driving the Upside?
by Zacks Equity Research
Demand for vital products amid the coronavirus pandemic and the acquisition of Albea's dispensing business has been driving Silgan's (SLGN) price performance.
Caterpillar (CAT) Hits 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Amid COVID-19 related woes, Caterpillar's (CAT) continues to focus on cost management, investing in enhancing digital capabilities, and introducing productive and efficient products.
Can Silgan (SLGN) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Silgan (SLGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
4 Top Industrial Stocks to Bet on as U.S Manufacturing Expands
by Zacks Equity Research
As the U.S. manufacturing sector continues to expand for the fourth straight month, we suggest four promising industrial stocks with positive growth projections for your portfolio.
3 Reasons Why Growth Investors Shouldn't Overlook Silgan (SLGN)
by Zacks Equity Research
Silgan (SLGN) could produce exceptional returns because of its solid growth attributes.
What Makes Silgan (SLGN) an Attractive Investment Pick
by Zacks Equity Research
Apart from forecast-topping Q2 results, solid growth projections and positive revision activity, let's have a look at some other factors that make Silgan (SLGN) a lucrative investment option.
Reasons to Add John Bean Technologies (JBT) to Your Portfolio
by Zacks Equity Research
Innovative products, successful acquisitions and its restructuring program will drive growth for John Bean Technologies (JBT).
Avery Dennison Gains on High-Value Products, Cost Actions
by Zacks Equity Research
Avery Dennison (AVY) well poised to benefit from cost savings, restructuring activities and growth in high-value product categories.
Deere (DE) Hits 52-Week High: What's Driving the Upside?
by Zacks Equity Research
Improved outlook, robust farm equipment demand, expansion initiatives and solid estimate revisions are contributing to the rally in Deere's (DE) shares.
Apogee's (APOG) Earnings Surpass Estimates in Q2, Up Y/Y
by Zacks Equity Research
Apogee's (APOG) Q2 top line declines on lower volumes across its business segments on account of the coronavirus pandemic.
What Makes Sealed Air (SEE) an Attractive Investment Pick
by Zacks Equity Research
Apart from forecast topping Q2 results, impressive earnings surprise history and solid growth projections, let's have a look at some factors that make Sealed Air (SEE) a lucrative investment option.